KRAS and familial pancreatic carcinoma: Using immunohistochemistry analysis, we also found that expression of HER-2 and EGFR was increased in the HPNE/K-ras/p16sh tumors compared with human normal pancreatic duct, similar to human pancreatic cancers (Fig.5D).